Introduction to National Medicines Policy in Relation to Pharmaceutical Services – PST05102 Law and Policies in Pharmacy Practice

NTA Level 5 • Semester 1 • PST05102

Introduction to National Medicines Policy in Relation to Pharmaceutical Services

Law and Policies in Pharmacy Practice • Source Session/Topic 13
Full source-text version: all educational wording from the extracted learning source is retained; only presenter/tutor metadata and web-layout noise are removed, while formatting is improved for readability.

Session 13: Introduction to National Medicines Policy in Relation to Pharmaceutical Services

Total Session Time: 120 minutes

Prerequisites

None

Learning Tasks

By the end of this session students are expected to be able to:

Define the terms

Policy

National medicine/drug Policy

List Steps in formulating National medicine policy.

List Elements of National Medicine Policy.

Mention Common Components of National Medicine Policy.

Explain Tasks of National Medicine Policy.

Strategies to implement National Medicine Policy.

Explain challenges to implementation of National Medicine Policy.

Resources Needed:

Flip charts, marker pens, and masking tape

Black/white board and chalk/whiteboard markers

SESSION OVERVIEW

Step

Time

Activity/

Method

Content

1

5 minutes

Presentation

Introduction, Learning Tasks

2

10 minutes

Presentation Buzzing

Definition of the Terms Policy and National Medicine/Drug Policy.

3

10 minutes

Presentation

Elements of National Medicine Policy.

4

15 minutes

Presentation

Common Components of National Medicine Policy.

5

15 minutes

Presentation

Tasks of National Medicine Policy.

6

30 minutes

Presentation

Strategies to Implement National Medicine Policy.

7

25 minutes

Presentation

Challenges to Implementation of National Medicine Policy.

8

5 minutes

Presentation

Key Points

9

5 minutes

Presentation

Evaluation

SESSION CONTENTS

STEP 1: Presentation of Session Title and Learning Tasks (5 minutes)

READ or ASK students to read the learning Tasks and clarify

ASK students if they have any questions before continuing.

STEP 2: Definition of the Terms Policy and National medicine/drug Policy. (10 minutes)

Activity: Buzzing (5 minutes)

PROVIDE students with the Pharmacy Act 2011 and Pharmacy Practice Regulations 2012

ASK students to pair up and buzz on the following question for 5 minutes

Define the following terms;

Policy

National medicine policy

ALLOW few pairs to respond

WRITE their responses on the flip chart/ board

CLARIFY and SUMMERIZE by using the content bellow

Policy: Defined as a system of laws, regulatory measures, courses of action, and funding priorities concerning a given topic promulgated by a governmental entity or its representatives.

National medicine/drug Policy: Is the policy, usually of a government, regarding the control and regulation (access, quality and rational use) of drugs considered dangerous, particularly those which are addictive.

STEP 3: Elements of National Medicine Policy. (5 minutes)

The following are steps in formulating National medicine policy

Organizing the process.

Identifying and analysing problems.

Setting goals and Tasks.

Drafting the policy.

Seeking wide agreement on the policy.

Obtaining formal endorsement of the policy.

Launching the policy.

STEP 4: Common Components of National Medicine Policy. (10 minutes)

Those five elements has the common components of national medicine policy which are;

Legislative and regulatory framework e.g. Drug regulatory authority.

Selection of essential medicine.

Supply.

Rational use of medicine.

Affordability.

Financial strategies for medicines.

Human resources development.

Monitoring and evaluation.

Research.

STEP 5: Common Components of National Medicine Policy. (15 minutes)

A national drug policy is a comprehensive framework in which each component plays an important role in achieving one or more of the general Tasks of the policy (access, quality, and rational use).

The following are explanation of key components of a National Medicine Policy;

Selection of essential medicines: Drug selection, preferably linked to national clinical guidelines, is a crucial step in ensuring access to essential drugs and in promoting rational drug use.

Affordability: Affordable prices are an important prerequisite for ensuring access to essential drugs in the public and private sectors. Eg government commitment to ensuring access through increased affordability

Drug financing: Drug financing is another essential component of policies to improve access to essential drugs, eg increased government funding for priority diseases, and the poor and disadvantaged, guidelines for drug donations, and commitment to measures to improve efficiency and reduce waste.

Supply systems: The fourth essential component of strategies to increase access to essential drugs is a reliable supply system, through: public–private mix in drug supply and distribution systems, inventory control, prevention of theft and waste, disposal of unwanted or expired drugs, publication of price information on raw materials and finished products, drug supply systems in acute emergencies and commitment to good pharmaceutical procurement practices in the public sector.

Rational use: The rational use of drugs means that patients receive medicines appropriate for their clinical needs, in doses that meet their individual requirements, for an adequate

period of time, and at the lowest cost to them and their community, this can be done through;

Promotion of the concepts of essential drugs, rational drug use and generic

Prescribing in basic and in-service training of health professionals;

The need and potential for training informal drug sellers;

Continuing education of health care providers and independent, unbiased drug information;

Consumer education, and ways to deliver it;

Financial incentives to promote rational drug use

Research: Operational research facilitates the implementation, monitoring and evaluation of different aspects of drug policy, so is an important tool that apart from other issues it assesses the drug policy’s impact on national health service systems and delivery, in studying the economics of drug supply, in identifying problems related to prescribing and dispensing, and in understanding the sociocultural aspects of drug use.

Human resource development: Human resources development includes the policies and strategies chosen to ensure that there are enough trained and motivated personnel available to implement the components of the national drug policy, eg definition of minimum education and training requirements for each category of staff.

Monitoring and evaluation: Monitoring and evaluation are essential components of a national drug policy, and the necessary provisions need to be included in the policy.

Key policy issues are:

Explicit government commitment to the principles of monitoring and evaluation.

Monitoring of the pharmaceutical sector through regular indicator-based surveys.

Independent external evaluation of the impact of the national drug policy on all sectors of the community and the economy.

STEP 6: Tasks of National Medicine Policy. (30 minutes)

The common specific Tasks of a national medicine policy are;

To make essential medicine available and affordable to those who need them.

To ensure the safety, efficacy and quality of all medicines provided to the public and private sectors.

To improve prescribing and dispensing practice.

To promote ethical practice among health professions and correct medicine use among health workers and consumers.

To ensure efficient and effective drug management in the public and private sectors.

To ensure access to safe, effective, affordable and good quality drugs at all levels of health care on the basis of health needs.

To promote the rational use of drugs by prescribers, dispensers and consumers.

To increase local drug manufacture/production and promote export;

To ensure that all drugs in the national drug distribution system are safe, efficacious, effective and of good quality.

STEP 7: Strategies to implement National Medicine Policy. (25 minutes)

In order to implement national medicine policy we must;

Use appropriate timing and combination of approach

Adopt a flexible policy

Use experts to vouch for policy’s technical soundness

Mobilize consumer, the media or other key groups

Create constituencies that support the policy outside and inside the country.

STEP 8: Challenges to Implementation of National Medicine Policy. (30 minutes)

Sometimes implementation of national medicine policy becomes is difficult due to the following reasons;

Lack of political will

Lack of resources

Opposition from those who benefit from laisse’s fair approach

Corruption

Support of domestic and international interest group

Macroeconomic situation

Technical expertise

STEP 9: Key Points (5 minutes)

Policy: Defined as a system of laws, regulatory measures, courses of action, and funding priorities concerning a given topic promulgated by a governmental entity or its representatives National medicine/drug Policy: Is the policy, usually of a government, regarding the control and regulation (access, quality and rational use) of drugs considered dangerous, particularly those which are addictive

STEP 10: Evaluation (5 minutes)

What is National Medicine Policy?

What are the goals of National Medicine Policy?

What is Drug Policy?

References

MSH and WHO (2012). Managing Access to Medicines and Health Technology, (3rd Edition). Kumarian Press

MoHSW (2003). Tanzania, Food, Drugs and Cosmetics Act, Government Printers Dar es Salaam

MoHSW (2011). Pharmacy Act, Government Printers Dar es Salaam

United Republic of Tanzania (1971). the drugs and prevention of illicit traffic in drugs act, Government Printers Dar es Salaam

United Republic of Tanzania (2011). Public Procurement Act, Dar es Salaam

MoHSW (2003). The National Health Policy, Government Printers Dar es Salaam

MoHSW (1991). The National Drug Policy, Government Printers Dar es Salaam

United Republic of Tanzania (1993).Medical Stores Department Act, Government Printers Dar es Salaam

Figure 2f from: Irimia R, Gottschling M (2016) Taxonomic revision of Rochefortia Sw. (Ehretiaceae, Boraginales). Biodiversity Data Journal 4: E7720. https://doi.org/10.3897/BDJ.4.e7720. (n.d.). doi:10.3897/bdj.4.e7720.figure2f

PDF / OFFLINE NOTES

Unataka kutumiwa notes hizi kupitia WhatsApp?Kwa notes zilizopangiliwa vizuri kwa kusoma offline au PDF, bonyeza kitufe hapa chini. Ujumbe wenye Level, Semester, Module na Topic utaandaliwa moja kwa moja.TUMIWA NOTES WHATSAPP

WhatsApp: 255620339260
banner
Scroll to Top